Cargando…

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin

Our previous studies have found that osteopontin (OPN) is a promoter for hepatocellular carcinoma (HCC) progression. However, the molecular mechanism by which OPN enhances HCC metastasis remains elusive. Epithelial-mesenchymal transition (EMT) of cancer cells plays a pivotal role in promoting metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Qiongzhu, Zhu, Xuchao, Dai, Chun, Zhang, Xiaofei, Gao, Xiaomei, Wei, Jinwang, Sheng, Yuanyuan, Zheng, Yan, Yu, Jian, Xie, Lu, Qin, Yi, Qiao, Peng, Zhou, Chuang, Yu, Xinxin, Jia, Huliang, Ren, Ning, Zhou, Haijun, Ye, Qinghai, Qin, Lunxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914337/ https://www.ncbi.nlm.nih.gov/pubmed/26824421 http://dx.doi.org/10.18632/oncotarget.7016

Ejemplares similares

Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice
por: LI, GUOCAI, et al.
Publicado: (2013)

Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma
por: Wei, Jinwang, et al.
Publicado: (2019)

Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
por: Gao, Xiaomei, et al.
Publicado: (2018)

Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
por: Gao, Xiaomei, et al.
Publicado: (2023)

Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma
por: Zeng, Lingyao, et al.
Publicado: (2012)

An integrative strategy for quantitative analysis of the N-glycoproteome in complex biological samples
por: Wang, Ji, et al.
Publicado: (2014)

CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015)

Osteopontin facilitates tumor metastasis by regulating epithelial–mesenchymal plasticity
por: Jia, Rongjie, et al.
Publicado: (2016)

Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
por: Kothari, Anai N., et al.
Publicado: (2016)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics
por: Shen, Xiaotian, et al.
Publicado: (2020)

CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
por: Fu, Yan, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma
por: Ci, Hongfei, et al.
Publicado: (2023)

Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner
por: Qin, Zhaoyu, et al.
Publicado: (2019)

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR
por: Shao, Weiqing, et al.
Publicado: (2019)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3
por: Sun, Haoting, et al.
Publicado: (2021)

Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
por: Wang, Hao, et al.
Publicado: (2021)

Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
por: Ho, Nguyen-Tuong, et al.
Publicado: (2022)

Regulatory roles of osteopontin in human lung cancer cell epithelial‐to‐mesenchymal transitions and responses
por: Shi, Lin, et al.
Publicado: (2021)

The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma
por: Niknami, Zohreh, et al.
Publicado: (2017)

The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
por: Fang, Tianyi, et al.
Publicado: (2022)

Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes
por: Iqbal, Jawed, et al.
Publicado: (2014)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis
por: You, Hongjuan, et al.
Publicado: (2021)

Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
por: Cerne, Katarina, et al.
Publicado: (2019)

Alcohol exposure decreases osteopontin expression during fracture healing and osteopontin-mediated mesenchymal stem cell migration in vitro
por: Natoli, Roman M., et al.
Publicado: (2018)

Retraction: Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes
Publicado: (2019)

Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
por: Myong, Na-Hye
Publicado: (2012)

Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
por: Liu, Ching-Yi, et al.
Publicado: (2015)

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Advanced Maternal Age‐associated SIRT1 Deficiency Compromises Trophoblast Epithelial−Mesenchymal Transition through an Increase in Vimentin Acetylation
por: Xiong, Liling, et al.
Publicado: (2021)

Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer
por: Zheng, Yan, et al.
Publicado: (2020)

Regulatory roles of Osteopontin in lung epithelial inflammation and epithelial‐telocyte interaction
por: Fu, Huirong, et al.
Publicado: (2023)

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial–mesenchymal transition-related proteins
por: Liu, Pei-Feng, et al.
Publicado: (2017)

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
por: Albertsson, Anna-Maj, et al.
Publicado: (2014)

RUNX3 regulates vimentin expression via miR-30a during epithelial–mesenchymal transition in gastric cancer cells
por: Liu, Zhifang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m7r6njeb2aaer0im5chflak6o0